Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.22.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock - Number of Shares, Shares Issued
Common Stock - Number of Shares, Shares Issued
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock - Number of Shares, Treasury Shares
Common Stock - Number of Shares, Treasury Shares
Cumulative Effect Period of Adoption Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect Period of Adoption Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect Period of Adoption Adjustment
Retained Earnings
Cumulative Effect Period of Adoption Adjusted Balance
Balance at beginning of period at Dec. 31, 2019 $ 563,267     $ 33   $ (116,515)   $ 575,816   $ 3,382   $ 100,551    
Balance at beginning of period (ASU 2016-13) at Dec. 31, 2019   $ (12,167)                     $ (12,167)  
Beginning balance, shares issued (shares) at Dec. 31, 2019       33,475,402 33,475,402                  
Beginning balance, treasury stock (shares) at Dec. 31, 2019           2,675,778 2,675,778              
Beginning balance, shares outstanding (shares) at Dec. 31, 2019       30,799,624 30,799,624                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Restricted stock awards, net of forfeitures (shares)       85,399                    
Share-based compensation expense 2,544             2,544            
Restricted stock surrendered due to employee tax liability (335)         $ (335)                
Restricted stock surrendered due to employee tax liability (shares)       (31,788)   (31,788)                
Repurchase of common stock (2,196)         $ (2,196)                
Repurchase of common stock (shares)       (135,400)   (135,400)                
Cash dividends paid (common stock, $0.52/share, $0.54/share, $0.94/share) (15,960)                     (15,960)    
Net income 42,196                     42,196    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (306)                 (306)        
Balance at end of period at Dec. 31, 2020 577,044     $ 33   $ (119,046)   578,360   3,076   114,621    
Ending balance, shares issued (shares) at Dec. 31, 2020       33,560,801                    
Ending balance, treasury stock (shares) at Dec. 31, 2020           (2,842,966)                
Ending balance, shares outstanding (shares) at Dec. 31, 2020       30,717,835                    
Adjusted balance at Dec. 31, 2019     $ 551,100   $ 33   $ (116,515)   $ 575,816   $ 3,382     $ 88,384
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Restricted stock awards, net of forfeitures (shares)       43,038                    
Share-based compensation expense 2,436             2,436            
Restricted stock surrendered due to employee tax liability (572)         $ (572)                
Restricted stock surrendered due to employee tax liability (shares)       (24,953)   (24,953)                
Repurchase of common stock (6,135)         $ (6,135)                
Repurchase of common stock (shares)       (328,659)   (328,659)                
Cash dividends paid (common stock, $0.52/share, $0.54/share, $0.94/share) (16,514)                     (16,514)    
Net income 98,677                     98,677    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (11,519)                 (11,519)        
Balance at end of period at Dec. 31, 2021 $ 643,417     $ 33   $ (125,753)   580,796   (8,443)   196,784    
Ending balance, shares issued (shares) at Dec. 31, 2021       33,603,839                    
Ending balance, treasury stock (shares) at Dec. 31, 2021 (3,196,578)         (3,196,578)                
Ending balance, shares outstanding (shares) at Dec. 31, 2021       30,407,261                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock options exercised $ 19             19            
Stock options exercised (shares)       1,500   1,500                
Restricted stock awards, net of forfeitures (shares)       104,395                    
Share-based compensation expense 2,595             2,595            
Restricted stock surrendered due to employee tax liability (732)         $ (732)                
Restricted stock surrendered due to employee tax liability (shares)       (27,535)   (27,535)                
Cash dividends paid (common stock, $0.52/share, $0.54/share, $0.94/share) (28,636)                     (28,636)    
Net income 101,394                     101,394    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (80,542)                 (80,542)        
Balance at end of period at Dec. 31, 2022 $ 637,515     $ 33   $ (126,485)   $ 583,410   $ (88,985)   $ 269,542    
Ending balance, shares issued (shares) at Dec. 31, 2022       33,708,234                    
Ending balance, treasury stock (shares) at Dec. 31, 2022 (3,222,613)         (3,222,613)                
Ending balance, shares outstanding (shares) at Dec. 31, 2022       30,485,621